AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Aroglim-M 2mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Arrowin Pharmaceuticals

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Aroglim-M 2mg/500mg Tablet

DiaBeta-Duo 2mg/500mg tablets are classified as antidiabetic agents, a combination medication for adult-onset type 2 diabetes. This dual-action formulation assists in regulating blood glucose. DiaBeta-Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled glucose levels, as abrupt cessation can lead to elevated blood sugar, increasing the risk of complications like kidney impairment, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as recommended by your healthcare provider. Lifestyle choices are integral to effective diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, manifesting as sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart conditions should inform their doctor before initiating treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is necessary, along with potential blood tests to track blood cell counts and liver function.

Uses of Aroglim-M 2mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Aroglim-M 2mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Aroglim-M 2mg/500mg tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.

Common Side effects of Aroglim-M 2mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Aroglim-M 2mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Aroglim-M 2mg/500mg tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

How Aroglim-M 2mg/500mg Tablet works:

A tablet combining 2mg glimepiride and 500mg metformin, Aroglim-M, offers dual antidiabetic action. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Aroglim-M 2mg/500mg tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Aroglim-M 2mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing this medication. Seek medical advice.

Breast feedingBreast feedingUNSAFE

The medication Aroglim-M 2mg/500mg tablets should not be taken while breastfeeding due to the potential for infant harm from the drug's components.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Aroglim-M 2mg/500mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Aroglim-M 2mg/500mg tablets are contraindicated in patients with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Aroglim-M 2mg/500mg tablets cautiously, potentially requiring dose modification. Consult a physician. For those with mild to moderate liver disease, initiate treatment with a low dose of Aroglim-M 2mg/500mg tablets; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Aroglim-M 2mg/500mg Tablet :

Should you forget to take your Aroglim-M 2mg/500mg Tablet, administer it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Aroglim-M 2mg/500mg Tablet

LabelValue
Potential for Dependence None.
Medication Classification Diabetes medication

FAQs on Aroglim-M 2mg/500mg Tablet

Maintain this medication within its original, sealed container. Follow the storage guidelines provided on the packaging. Discard any remaining medication. Ensure it remains inaccessible to children, pets, and others.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential consequence of taking Aroglim-M 2mg/500mg tablets. Also termed Metformin-associated lactic acidosis (MALA), this rare but severe adverse reaction is particularly risky for individuals with kidney impairment, the elderly, or those who consume significant quantities of alcohol. Symptoms can manifest as muscle aches or weakness, lightheadedness, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, or a slow pulse. Should any of these symptoms arise, discontinue Aroglim-M 2mg/500mg tablet use and seek immediate medical attention.
A combination tablet, Aroglim-M 2mg/500mg, contains glimepiride and metformin. This medication manages type 2 diabetes mellitus in adults, enhancing blood sugar control when combined with a healthy diet and physical activity. Glimepiride stimulates insulin secretion from the pancreas, thereby reducing blood glucose. Metformin acts by decreasing hepatic glucose production and increasing insulin responsiveness. This formulation is unsuitable for managing type 1 diabetes.
Aroglim-M 2mg/500mg tablets may cause common side effects including low blood sugar, taste changes, nausea, abdominal discomfort, loose stools, and headache. Rare but potentially serious adverse reactions such as lactic acidosis may occur. Prolonged use might result in vitamin B12 deficiency.
Prolonged Aroglim-M 2mg/500mg Tablet use can indeed lead to Vitamin B12 deficiency. This medication impairs Vitamin B12 absorption within the gastrointestinal tract. Consequently, untreated deficiency may result in anemia, neurological complications such as paresthesia in the extremities, muscle weakness, urinary dysfunction, cognitive impairment, and gait disturbances. To mitigate these risks, supplemental Vitamin B12 intake, at least annually, is recommended by some studies.
Indeed, Aroglim-M 2mg/500mg tablets may induce hypoglycemia (low blood glucose). Manifestations of low blood sugar can encompass nausea, headache, irritability, hunger pangs, sweating, vertigo, tachycardia, and feelings of anxiety or tremor. The likelihood increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, regular blood glucose monitoring is crucial. Carrying a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice, is advisable.
Combining Aroglim-M 2mg/500mg tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and heighten the risk of lactic acidosis.
Aroglim-M 2mg/500mg Table...
41
MRP 50
17% off